Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atavistik Bio, Inc
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Rutgers, The State University of New Jersey
Seagen Inc.
University Health Network, Toronto
Sensei Biotherapeutics, Inc.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano